Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Share:

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2024, Vol. 29 ›› Issue (1): 99-106.doi: 10.12092/j.issn.1009-2501.2024.01.011

Previous Articles     Next Articles

Research progress on molecular mechanism of traditional chinese medicine active ingredients interfering bone marrow mesenchymal stem cells senescence

YU Miaoying1, WANG Yanhui2, YAN Shi3   

  1. 1 College of Life Science, Shangrao Normal University, Shangrao 334001, Jiangxi, China; 2 School of basic medicine, Jiangxi Medical College, Shangrao 334000, Jiangxi, China; 3 Health-Biotech Group, Jiangxi H&B Stem Cell Technology Limited Company, Shangrao 334100, Jiangxi, China

  • Received:2023-06-30 Revised:2023-09-13 Online:2024-01-26 Published:2024-01-15

Abstract:

The senescence of bone marrow mesenchymal stem cells (BM-MSCs) will induce age-related bone tissue degeneration and chronic inflammation, and reduce its application effect for cell therapy. More and more active ingredients of traditional chinese medicine have been proved to intervene BM-MSCs senescence, playing an important role in bone diseases prevention and treatment, and improving the therapeutic effect of BM-MSCs. In this paper, the latest research progress on the molecular mechanism of traditional chinese medicine active ingredients interfering BM-MSCs senescence was summarized, in order to provide new direction and reference basis for senescence intervention research and clinical application improvement of BM-MSCs.

Key words: bone marrow mesenchymal stem cells, senescence, traditional chinese medicine active ingredient, molecular mechanism

CLC Number: